PEMPHIGUS-VULGARIS - TREATMENT and EVOLUTION of 40 PATIENTS

PEMPHIGUS-VULGARIS - TREATMENT and EVOLUTION of 40 PATIENTS

Autor Porro, A. M. Google Scholar
Castro, R. M. Google Scholar
Almeida, F. A. Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo A retrospective study was conducted of 40 patients with pemphigus vulgaris seen in the period between 1965 and 1991. the time of follow-up of the patients ranged from 6 months to 25 years 8 months, with a mean of 4 years 10 months. the objective of the study was to assess the therapeutic response and evolution of the patients. All patients included in the study were treated with corticosteroids and 18 also received an adjuvant immunosuppressant. the maximum daily corticosteroid dose ranged 10 to 180 mg prednisone equivalent. Control of the pemphigus vulgaris was obtained in 37 (92.5%) of the 40 patients with a mean daily corticosteroid dose of 77.4 mg prednisone equivalent. After control, 54% of the patients relapsed. At the end of the study, 10 patients (25%) were without lesions and did not require treatment, 16 (40%) were without lesions and receiving treatment, 10 (25%) had lesions and were receiving treatment, 2 (5%) had died of unrelated causes, and 2 (5%) had died due to pemphigus vulgaris and/or its treatment, and in both of these the cause of death was septicaemia.
Palavra-chave PEMPHIGUS VULGARIS
Idioma Inglês
Data de publicação 1995-06-01
Publicado em Journal of Dermatological Treatment. London: Informa Healthcare, v. 6, n. 2, p. 99-102, 1995.
ISSN 0954-6634 (Sherpa/Romeo, fator de impacto)
Publicador Informa Healthcare
Extensão 99-102
Fonte http://dx.doi.org/10.3109/09546639509097160
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:A1995RK69700010
Endereço permanente http://repositorio.unifesp.br/handle/11600/25504

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta